ResearcherLithuanian University of Health SciencesActive in the last 2 years
Žilvinas Dambrauskas
Matched on ORCID iD 0000-0003-2173-1294; OpenAlex author ID A5063498025. Sources: OpenAlex.
Their work
- Papers
- 10 (first author 0, last author 7)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 11
2016: 1 paper · 2017: none · 2018: none · 2019: 2 papers · 2020: 1 paper · 2021: none · 2022: none · 2023: 2 papers · 2024: none · 2025: 2 papers · 2026: 2 papers
Papers 10
- Circulating cell-free DNA fragmentomics distinguishes pancreatic ductal adenocarcinoma from non-malignant conditions Co-author DOI 10.1007/s00423-026-04267-0↗
- Overexpression of EMT-related transcription factors SNAI1 and ZEB1 is associated with more aggressive clinicopathological features of pancreatic cancer. Co-author DOI 10.1371/journal.pone.0339964↗
- Small-molecule inhibitor BAY synergizes with gemcitabine through AHR inhibition in pancreatic cancer cells. Last author DOI 10.1016/j.bcp.2025.116798↗
- Baseline AHR expression shapes immune response to pharmacological modulation in PBMCs from pancreatic cancer patients. Last author DOI 10.3389/fimmu.2025.1655258↗
- Association between AHR Expression and Immune Dysregulation in Pancreatic Ductal Adenocarcinoma: Insights from Comprehensive Immune Profiling of Peripheral Blo… Co-author DOI 10.3390/cancers15184639↗
- Targeting AHR Increases Pancreatic Cancer Cell Sensitivity to Gemcitabine through the ELAVL1-DCK Pathway. Last author DOI 10.3390/ijms241713155↗
- Epigenetic Regulation of APAF-1 Through DNA Methylation in Pancreatic Cancer. Last author DOI 10.21873/anticanres.14366↗
- CT- and MRI-Based Assessment of Body Composition and Pancreatic Fibrosis Reveals High Incidence of Clinically Significant Metabolic Changes That Affect the Qua… Last author DOI 10.3390/medicina55100649↗
- Human antigen R mediated post-transcriptional regulation of inhibitors of apoptosis proteins in pancreatic cancer. Last author DOI 10.3748/wjg.v25.i2.205↗
- Upregulation of cugbp2 increases response of pancreatic cancer cells to chemotherapy. Last author DOI 10.1007/s00423-015-1364-1↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Antanas Gulbinas · 9 shared papers, 2016–2026 · strength 1.50
- Paper Overexpression of EMT-related transcription factors SNAI1 and ZEB1 is associated with more aggressive clinicopathologic… DOI 10.1371/journal.pone.0339964↗
- Paper Small-molecule inhibitor BAY synergizes with gemcitabine through AHR inhibition in pancreatic cancer cells. DOI 10.1016/j.bcp.2025.116798↗
- Paper Baseline AHR expression shapes immune response to pharmacological modulation in PBMCs from pancreatic cancer patients. DOI 10.3389/fimmu.2025.1655258↗
- Darius Stukas · 5 shared papers, 2023–2026 · strength 1.08
- Paper Circulating cell-free DNA fragmentomics distinguishes pancreatic ductal adenocarcinoma from non-malignant conditions DOI 10.1007/s00423-026-04267-0↗
- Paper Small-molecule inhibitor BAY synergizes with gemcitabine through AHR inhibition in pancreatic cancer cells. DOI 10.1016/j.bcp.2025.116798↗
- Paper Baseline AHR expression shapes immune response to pharmacological modulation in PBMCs from pancreatic cancer patients. DOI 10.3389/fimmu.2025.1655258↗
- Arenida Bartkevičienė · 5 shared papers, 2023–2026 · strength 1.08
- Paper Circulating cell-free DNA fragmentomics distinguishes pancreatic ductal adenocarcinoma from non-malignant conditions DOI 10.1007/s00423-026-04267-0↗
- Paper Small-molecule inhibitor BAY synergizes with gemcitabine through AHR inhibition in pancreatic cancer cells. DOI 10.1016/j.bcp.2025.116798↗
- Paper Baseline AHR expression shapes immune response to pharmacological modulation in PBMCs from pancreatic cancer patients. DOI 10.3389/fimmu.2025.1655258↗
- Giedrius Barauskas · 4 shared papers, 2019–2026 · strength 0.82
- Paper Overexpression of EMT-related transcription factors SNAI1 and ZEB1 is associated with more aggressive clinicopathologic… DOI 10.1371/journal.pone.0339964↗
- Paper Circulating cell-free DNA fragmentomics distinguishes pancreatic ductal adenocarcinoma from non-malignant conditions DOI 10.1007/s00423-026-04267-0↗
- Paper Epigenetic Regulation of APAF-1 Through DNA Methylation in Pancreatic Cancer. DOI 10.21873/anticanres.14366↗
- Povilas Ignatavičius · 3 shared papers, 2019–2026 · strength 0.71
- Paper Overexpression of EMT-related transcription factors SNAI1 and ZEB1 is associated with more aggressive clinicopathologic… DOI 10.1371/journal.pone.0339964↗
- Paper Circulating cell-free DNA fragmentomics distinguishes pancreatic ductal adenocarcinoma from non-malignant conditions DOI 10.1007/s00423-026-04267-0↗
- Paper CT- and MRI-Based Assessment of Body Composition and Pancreatic Fibrosis Reveals High Incidence of Clinically Significa… DOI 10.3390/medicina55100649↗
- Kęstutis Urbonas · 1 shared paper, 2026 · strength 0.33
- Romualdas Riauka · 1 shared paper, 2026 · strength 0.29
- Aušra Lukošiūtė - Urbonienė · 2 shared papers, 2019–2020 · strength 0.22
- Albertas Daukša · 2 shared papers, 2016–2020 · strength 0.17
- Edita Bieliūnienė · 1 shared paper, 2019 · strength 0.09
- Aldona Jakštaitė · 1 shared paper, 2016 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.